- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.12.24 | CRO Ora showcases key role music plays in the blind community | ||
| 12.12.24 | Lonza plans to shed capsules business, simplify operating structure in push to become 'pure-play' CDMO | ||
| 12.12.24 | Siga's smallpox antiviral Tpoxx misses the mark in another mpox study | ||
| 12.12.24 | SABCS: Under siege from competitors, Pfizer's Ibrance scores in double-positive breast cancer | ||
| 12.12.24 | Ex-NFL stars 'Gear Up' with CDC for colorectal cancer screening push | ||
| 11.12.24 | Trump names Andrew Ferguson as pick for FTC chair in potential win for biopharma dealmaking | ||
| 11.12.24 | With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033 | ||
| 11.12.24 | Lilly CEO Ricks provides hints on how Trump will approach healthcare issues | ||
| 11.12.24 | Vertex, Saudi Arabia ink memorandum of understanding to boost local gene therapy manufacturing | ||
| 11.12.24 | Daiichi Sankyo builds $152M ADC plant in China as Enhertu wins national coverage | ||
| 10.12.24 | CSL Vifor floats £23M offer, doctor outreach campaign in bid to resolve UK antitrust probe | ||
| 10.12.24 | High-flying Eli Lilly plots $15B share buyback plan | ||
| 10.12.24 | ASH: Eli Lilly touts novel BTK trial win for Jaypirca as execs defend survival data blemish | ||
| 09.12.24 | EuroAPI vaults operating chief into CEO role as it embarks upon 'new chapter' | ||
| 09.12.24 | Boehringer, Lilly bring 'It Takes 2' kidney disease testing push to 2025 Rose Parade | ||
| 09.12.24 | BioMarin to add €60M lab to Irish manufacturing site in push to grow production capacity | ||
| 09.12.24 | ASH: Catching up with bispecific rival AbbVie, Roche's subcutaneous Lunsumio matches IV version in lymphoma | ||
| 09.12.24 | ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep | ||
| 09.12.24 | AbbVie survey singles out emotional impact of CLL diagnosis on Black, Hispanic and Asian patients | ||
| 09.12.24 | Biosecure Act MIA from US defense bill in key win for China biopharma service providers | ||
| 09.12.24 | Amgen's Blincyto keeps 96% of pediatric leukemia patients alive and disease-free in 'practice changing' 3-year study | ||
| 09.12.24 | Merck gets rare win with Keytruda-Lynparza combo but role of Keytruda in ovarian cancer 'remains uncertain' | ||
| 09.12.24 | Omnicom, Interpublic ink merger to create world's largest ad agency | ||
| 09.12.24 | Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead | ||
| 08.12.24 | ASH: AstraZeneca proposes fixed-duration Calquence combos in chronic lymphocytic leukemia |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
